How Can AI Reduce Claim Denials? The 3-Column Map of What It Can and Can't Fix

TLDR: How can AI reduce claim denials? In three places, and only three: matching clinical documentation to payer requirements before submission, ranking the denial worklist by revenue at risk instead of arrival order, and drafting patient-specific appeals. AI cannot fix wrong intake data, documentation the clinician never wrote, or a payer policy designed to deny. The honest map, called the 3-Column Denial Map here, is what a VP of revenue cycle needs before the board hears the word "AI".

Best For: VPs and SVPs of Revenue Cycle and Directors of RCM or Payer Operations at US provider, lab, and diagnostics enterprises with 1,000 to 15,000 employees who have just quantified their denial write-offs and have been asked for a plan.

AI for claim denials is a class of software that reads claims, clinical notes, and payer rules to predict which claims will be denied, rank the ones that were, and draft the response. That is a narrower job than the phrase "AI will fix denials" implies, and the gap between the two is where revenue cycle leaders get hurt. According to Experian Health's 2025 State of Claims survey, 41% of providers now say more than 10% of their claims are denied, up from 30% in 2022, and only 14% are using AI on the problem. The number is big, and the temptation is to tell the board that automation will make it go away. This post lays out where AI reduces denials, where it does so only if you have done other work first, and where it does nothing at all.

How can AI reduce claim denials? The short answer

AI reduces claim denials by doing three specific jobs: checking that the documentation attached to a claim matches what the payer's policy requires, sorting the denial worklist by dollars and deadline rather than first in, first out, and drafting appeals that cite the patient's chart and the payer's own policy. Every other claimed benefit is either one of these three in disguise or a promise that depends on data the organization may not have.

That is the whole answer, and the rest of this post is about the conditions attached to it. The three jobs above are real. In McKinsey's 2025 revenue cycle survey, published April 2026, 57% of care delivery leaders named denial management and appeals automation as a top priority, and 51% named AI as a priority focus, up from 33% a year earlier. Interest is not the constraint. The constraint is that most of the denial problem lives upstream of the point where AI is usually bolted on.

The 3-Column Denial Map

The map below is the one tool this post asks you to keep. Every denial category your data team can name belongs in one of three columns. The first column is work AI does well today. The second is work AI does well only if a named condition is met. The third is work AI cannot do, no matter what the demo showed.

If your quantified write-off sits mostly in column three, an AI purchase will not move it. That is an uncomfortable sentence to put in a board pre-read. It is also the one that saves you the next three quarters.

Why claim denials keep rising, and why more automation is not fewer denials

Claim denials are rising because payers have automated their side of the adjudication first, and because provider intake data and documentation have not kept pace. A denial is a claim the payer has adjudicated and refused to pay; it is different from a rejection, which never entered adjudication, and from a write-off, which is a denial the provider stopped fighting. Most AI marketing blurs the three. The distinctions decide what AI can touch.

Denial vs. rejection vs. write-off

A rejection is a formatting or eligibility failure caught by the clearinghouse or payer front end; it never reaches a medical reviewer. A denial is a decision. A final denial write-off is the accounting result when the appeal window closes. A 2025 benchmarking analysis reported by HealthLeaders across 2,300 hospitals put the initial denial rate at 11.6% and the median final denial rate at 2.7% of revenue, with the top quartile at 1.6%. The gap between the initial and final numbers is the work. AI helps most in that gap, and least at the two ends.

How the problem got here

Ten years ago denial management was a back-office function: coders working a queue, oldest first. Payers then invested in automated utilization review; HFMA reported in 2026 that initial denial rates rose again in 2025 and that roughly 70% of appealed denials are ultimately overturned, which is another way of saying most denials were not about the care. Premier's survey of 516 hospitals found that nearly 15% of private payer claims were denied on first pass and 54.3% of those were eventually paid. Providers are now buying AI to answer AI. That is a legitimate move, but it changes nothing about the intake and documentation errors that started the claim off wrong.

The board's mental model is the risk

The 2025 AMA prior authorization survey found that six in ten physicians worry that AI will increase denial rates rather than reduce them. Board members read the same headlines and draw the opposite conclusion: if payers use AI to deny, our AI should get it back. The revenue cycle leader is caught between a clinical staff that expects AI to make things worse and a board that expects it to make things better. The honest map is how you hold both.

Where AI reduces claim denials: the three jobs it does well

AI reduces claim denials most reliably in three places: pre-submission documentation matching, revenue-at-risk prioritization of the denial worklist, and drafting of payer-specific appeals. Each has a clear input and output, and each can be measured inside a single payer, which is what makes them safe to pilot and safe to report.

1. Documentation matching before the claim goes out

Payers deny when the documentation on the claim does not support the code. AI that reads the clinical note and the payer's coverage policy side by side can flag the gap before submission. This is the highest-yield use, because it prevents rather than recovers. MGMA's 2024 poll of 235 medical groups found that 60% saw denials rise year over year, with "insufficient documentation" among the top payer reasons cited. The precondition is that the note exists and the policy is codified per payer and per plan. If your organization's medical policy library is a shared drive of PDFs, the AI will match against nothing.

2. Ranking the denial worklist by revenue at risk

Most denial queues are worked in the order they arrived. AI can re-rank them by balance, payer appeal deadline, clinical readiness, and historical overturn probability for that payer and reason code. McKinsey's April 2026 analysis found that organizations with a dedicated, standardized denial prevention process achieve 47% appeal success rates against 37% to 42% for those without, and that 64% of organizations have no denial prevention infrastructure at all. The ranking model does not create appeals capacity; it points the capacity you have at the money that can still be recovered. The precondition is a single queue with populated fields. That precondition is the subject of the next post in this series.

3. Drafting patient-specific, policy-specific appeals

Generic appeal templates get discarded by payer medical directors. AI can draft an appeal that quotes the patient's chart and the payer's own medical policy, then hand it to a clinician or nurse reviewer to sign. HHS OIG reported in June 2026 that Medicare Advantage plans overturned 95% of appealed skilled nursing denials, yet only 18% of denials were appealed. The unappealed 82% is where drafting capacity matters. The precondition is chart access and a clinical argument that already exists somewhere in the record. AI can find it and phrase it; it cannot invent it.

What AI cannot do for claim denials without clean data and clinical documentation

AI cannot reduce claim denials that originate in wrong intake data, in clinical documentation that was never created, or in payer policy that is designed to deny first and pay on appeal. These three categories are not edge cases. In most provider organizations they account for the majority of final write-offs, and they are the categories AI vendors are least eager to discuss.

Bad intake data

A claim with the wrong member ID, plan, or subscriber date of birth is denied before any clinical review. Experian Health's 2025 survey found that 54% of providers say claim errors are increasing and 26% trace at least one in ten denials to intake errors. AI can flag a suspicious registration if the source data is validated against eligibility responses. It cannot correct a field nobody checked. This is a front-desk process and a data validation problem, and the honest map puts it in column three until intake is fixed.

Missing clinical documentation

If the physician did not document medical necessity, there is nothing to match and nothing to appeal. The 2025 AMA survey found physicians complete an average of 40 prior authorizations per week, consuming 13 hours of physician and staff time; documentation shortcuts under that load are predictable. AI can prompt for missing elements at the point of documentation, which is a clinical workflow change, not a revenue cycle tool. Buying appeal-drafting AI to compensate for absent notes produces confident letters with nothing behind them, and payer medical directors recognize them on the first page.

Payer policy and contract terms

KFF's analysis of 2024 marketplace claims found insurers denied about 19% of in-network claims, with rates ranging from 3% to 36% by insurer, and that 36% of denials were coded simply as "other". Fewer than 1% of denied claims were appealed by consumers, and 66% of those appeals were upheld. A payer whose business model relies on that appeal drop-off will not be out-modeled by your software. What changes payer behavior is a payer-by-payer denial report, validated by your own data team, taken into contract negotiation. AI can help build that report. It cannot negotiate.

For a provider whose quantified write-off is concentrated in two or three payers, whose denials are spread across multiple systems, and whose board has already been told AI is the plan, a generic denial tool is not enough. The answer is a dedicated build that does three things in order: consolidates denials, appeals, authorizations, and reimbursements into validated master tables that the revenue cycle team owns; ranks the worklist by revenue at risk using those tables and each payer's appeal window; and only then places AI on documentation matching and appeal drafting for the one payer where the data is cleanest. Anything that skips the first step is automating the current mess.

AI denial management vs. denial automation vs. outsourced denial services

AI denial management, rules-based denial automation, and outsourced denial services solve different problems and are routinely confused in vendor decks. Automation executes fixed rules on structured fields. AI reads unstructured notes and policies and makes a judgment. Outsourcing moves the labor and the data to a third party. A VP of revenue cycle should know which one they are being sold before the pilot starts.

CAQH's 2024 Index estimated that moving prior authorization to the electronic standard saves providers 14 minutes per authorization and that automating claim status inquiries saves up to 18 minutes per patient visit. Those are automation wins, not AI wins, and many organizations have not taken them yet. MGMA reported in 2024 that most group practices have 40% or less of revenue cycle operations automated. Doing the rules-based work first makes the AI work smaller and cleaner. A broader view of where healthcare operations should start with AI is in Assembly's healthcare AI use case guide.

How can AI reduce claim denials without the board believing the process is fixed?

AI reduces claim denials credibly when it is piloted on one payer, measured against a baseline the revenue cycle team's own data analysts validated, and reported as a change in a specific denial category rather than as a program. That sequencing protects the leader from the outcome they fear most: a board that believes automation of the current process has solved a problem that is mostly upstream.

Pick one payer and one denial reason

Choose the payer with the highest final denial rate where your data is cleanest, and a single reason code where documentation exists. The HHS OIG data showing denial rates from 0.4% to 23% across Medicare Advantage organizations is a reminder that payer behavior is not one thing. A pilot on "denials" proves nothing; a pilot on one payer's medical necessity denials for one service line can be validated by your own team in a quarter.

Baseline with your own numbers, not the vendor's

The instinct of every revenue cycle leader I have worked with is correct: distrust the vendor's opportunity sizing. Before the pilot, record the initial denial rate, appeal rate, overturn rate, days to appeal, and write-off for that payer and reason over the prior two quarters. McKinsey's January 2026 analysis notes that as many as 60% of denied claims are never appealed; if your pilot's only effect is that more denials get appealed, that is a capacity finding, not an AI finding, and it should be reported as one. A useful checklist for the underlying data work is Assembly's AI data readiness framework.

Report a category, not a program

The board pre-read should say: "Medical necessity denials for payer X fell from A% to B% over the quarter; appeal overturns rose from C% to D%; the tool was applied to this category only; intake and documentation denials were unchanged and are being addressed through registration and clinical workflow." That last clause is the protection. It is also the argument for the modernization sequence health systems are adopting, where AI is the reason to fix the foundation rather than a substitute for fixing it.

The hardest questions a VP of revenue cycle asks about AI and denials

Revenue cycle leaders push back on AI for denials in three consistent ways, and each objection is mostly right. The useful response is to show which column of the map the objection belongs in.

"Our denials are a payer problem, not a process problem." Partly true, and column three is real. But Premier's data showing 54% of denials eventually paid means the payer is testing your capacity to respond. AI in columns one and two raises that capacity; the payer-by-payer report built from the same data is your leverage in contract talks.

"We already have automation and denials still went up." Rules-based automation handles rejections and status checks. It does not read a note against a policy. HFMA reported in 2025 that only one in five providers uses AI in denials management even as 64% use it for documentation support. The denial queue is usually the last place AI arrives, not the first.

"If we show the board an AI result, they will cut the appeals team." That is the real fear and it is worth saying aloud. Bain and KLAS found in 2025 that 70% of providers now have an AI strategy, but many say it is still too early to quantify returns. Reporting AI results by denial category, with the human reviewer's role named in each, is what keeps the appeals team in the plan. Every pilot that fails to do this is documented in the process-first failure modes Assembly has catalogued.

Denials are going to keep rising. The 2026 McKinsey survey found 50% of care delivery leaders expect denials to increase further under current federal policy changes. AI belongs in the plan. The map decides where.

This analysis was developed using methodologies and operating experience from Assembly.

Frequently Asked Questions

How can AI reduce claim denials?

AI reduces claim denials in three places: matching clinical documentation to payer policy before submission, ranking the denial worklist by revenue at risk and appeal deadline, and drafting patient-specific appeals for a reviewer to sign. Each depends on accessible charts, codified payer rules, and a single denial queue with populated fields.

What is the 3-Column Denial Map?

The 3-Column Denial Map is a sorting tool that places every denial category into one of three columns: work AI fixes today, work AI fixes only if a named condition is met, and work AI cannot fix. Intake errors, missing clinical documentation, and payer policy sit in the third column until upstream processes change.

What are the main causes of claim denials in 2026?

The main causes of claim denials are registration and eligibility errors, missing or insufficient clinical documentation, absent prior authorization, and payer policy. KFF's 2024 analysis found 25% of marketplace denials were administrative and 36% were coded only as "other", which limits root-cause work.

Can AI predict which claims will be denied?

AI can predict likely denials when historical claims, payer responses, and documentation are available in one validated dataset. Prediction works best per payer and per reason code. It fails when denials are spread across several systems or when the training history reflects a payer whose rules have since changed.

Can AI write medical necessity appeal letters?

AI can draft medical necessity appeals that cite the patient's chart and the payer's own policy, which is what payer medical directors read. The draft still needs a nurse or physician reviewer to confirm the clinical argument. AI cannot supply a clinical justification that was never documented in the record.

What data does AI need to reduce claim denials?

AI needs validated master tables for claims, denials, appeals, authorizations, and reimbursements, keyed by payer and reason code, plus chart access and a codified library of payer medical policies. Experian Health's 2025 survey found 54% of providers say claim errors are increasing, which is the data problem in numbers.

What is the difference between AI denial management and denial automation?

Denial automation executes fixed rules on structured fields, such as claim status checks and clean resubmissions. AI denial management reads unstructured notes and payer policies and makes a judgment about documentation gaps or appeal arguments. Most organizations should finish the automation work before expecting AI to carry the denial queue.

Why do AI denial tools fail?

AI denial tools fail when they are placed on fragmented workflows with unvalidated data. McKinsey's April 2026 survey found 64% of organizations lack denial prevention infrastructure. AI applied on top of six systems and a spreadsheet multiplies handoffs rather than removing them.

What share of denied claims are eventually overturned?

More than half of denied claims are eventually paid when providers appeal. Premier's hospital survey found 54.3% of private payer denials were overturned, and HHS OIG reported in 2026 a 95% overturn rate on appealed Medicare Advantage skilled nursing denials.

How should a VP of revenue cycle pilot AI on denials?

A revenue cycle leader should pilot AI on one payer and one denial reason where documentation exists and data is cleanest. Baseline initial denial rate, appeal rate, overturn rate, and write-off for two prior quarters using internal analysts, then report the change in that category only.

Can AI fix denials caused by registration errors?

AI cannot fix registration denials caused by wrong member IDs or plan details entered at intake. It can flag suspicious registrations when intake data is validated against eligibility responses. The fix is front-desk process and data validation, which belong upstream of any denial tool.

Can AI help with prior authorization denials?

AI can help prior authorization denials only when order data reaches the revenue cycle before service is rendered. AMA's 2025 survey found physicians handle 40 prior authorizations every week. Once a service is delivered without authorization, no software recovers it.

How do you measure whether AI reduced denials?

AI's effect on denials is measured as the change in initial denial rate, appeal rate, overturn rate, and final write-off for a named payer and reason code against a two-quarter baseline. Increases in appeal volume alone are a capacity finding and should be reported separately from AI accuracy.

Should a provider build or buy AI for denials?

Providers with fragmented denial data should build the data foundation before buying any AI tool, because purchased tools assume a single queue and codified policies. Buying makes sense for narrow, well-defined tasks such as claim status automation. Building keeps outcome ownership and payer-level reporting inside the revenue cycle team.

Will AI make payers deny more claims?

Payers already use automated review, and HFMA reported in 2026 that initial denial rates rose again in 2025. Provider AI does not change payer strategy. It raises the provider's capacity to respond, and it produces the payer-by-payer evidence that changes contract negotiations.

What role should an outside partner play in AI for denials?

An outside partner is most useful for building the validated data foundation and the prioritization model, not for running the appeals queue. The right partner works from the provider's own numbers, pilots on one payer, and leaves the revenue cycle team owning the tables, the model, and the reporting to the board.